Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets
First time AI has been used to identify disease targets in RSVLONDON, UK / ACCESSWIRE / November 8, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious
Source: finanznachrichten.de